华东医药：2020年第一季度报告（英文版）.PDF

1、The First Quarterly Report 2020 of Huadong Medicine Co.,Ltd.1 Huadong Medicine Co.,Ltd.The First Quarterly Report 2020 April 2020 The First Quarterly Report 2020 of Huadong Medicine Co.,Ltd.2 Section I Important Declaration The Board of Directors,Board of Supervisors,directors,supervisors and senior

2、 management of Huadong Medicine Co.,Ltd.(hereinafter referred to as the“Company”)hereby guarantee that the information presented in this report is authentic,accurate and complete and free of any false records,misleading statements or material omissions,and shall undertake individual and joint legal

3、liabilities.All directors have attended the board of directors meeting to review this quarterly report.Lyu Liang,the Companys legal representative and the officer in charge of accounting,and Qiu Renbo,head of accounting department(accounting supervisor)hereby declare and guarantee that the financial

4、 statements in this quarterly report are authentic,accurate and complete.According to“Stock Listing Rules of the Shenzhen Stock Exchange”,if listed companies have both Chinese or other language version of public notice,they should ensure the content of both versions are the same.In the case of discr

5、epancy,the original version in Chinese shall prevail.The First Quarterly Report 2020 of Huadong Medicine Co.,Ltd.3 Section II Company Profile I.Key Accounting Data and Financial Indicators Whether the Company needs to perform retroactive adjustment or restatement of previous accounting data Yes No T

6、he current reporting period Same period last year Change of the current reporting period over the same period last year Operating revenue(yuan)8,598,069,911.29 9,705,148,188.21-11.41%Net profit attributable to shareholders of listed companies(yuan)1,147,278,457.64 907,244,647.77 26.46%Net profit att